MedPath

Quantitative T1rho Magnetic Resonance Imaging in Healthy Subjects

Not Applicable
Recruiting
Conditions
Magnetic Resonance Imaging
Interventions
Diagnostic Test: T1rho imaging
Registration Number
NCT04993196
Lead Sponsor
Chinese University of Hong Kong
Brief Summary

T1rho imaging is a new MRI technique that has strong potential in neuroimaging. This technique does not require exogenous contrast agents and has high spatial resolution.

In this study we aim to characterise the normal appearance of T1rho in the brain parenchyma in healthy participants. T1rho values will be measured in normal brain structures.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Male and female volunteers greater than or equal to 18 years of age
Read More
Exclusion Criteria
  • Subjects with a contraindication to magnetic resonance imaging such as the presence of metallic implants, claustrophobia and pregnancy.
  • Subjects with previous severe allergic or anaphylactoid reaction to a gadolinium contrast agent, or contraindication to contrast gadolinium administration, such severe renal disease or acutely deteriorating renal function, who would be at risk of nephrogenic systemic fibrosis
  • Subjects who are unable to tolerate the scan without moving the head as a result of symptoms such as tremor, spasticity, involuntary movements and spasms, cognitive impairment, coughing, and shortness of breath.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
T1rho MRIT1rho imaging-
Primary Outcome Measures
NameTimeMethod
T1rho value in normal grey and white matter in healthy volunteersUp to 2 months

T1rho value (measured on T1rho weighted MRI) in normal grey and white matter in healthy volunteers

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

CUHK

🇭🇰

Hong Kong, Hong Kong

© Copyright 2025. All Rights Reserved by MedPath